Follow The Filings

OM Outset Medical

Outset Medical earnings company data as of 4:46 AM ET 10/25

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by OM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OM insider trades
  • $870K bought by 1 insider
  • $6,765 sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Braden Michael Leonard 10% owner
    Buy
    $870K 244,909 shares at $3.55 +9.7% to stake
    Traded Oct 1–2 Filed Oct 5
    ↗
  2. Karen Drexler Director
    Sale
    $6,765 1,548 shares at $4.37 13% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 sales to cover taxes, 11 stock grants, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.